Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Takeda
Related studies linked through entity extraction aliases.
Vedolizumab Post Op Study
- Status
- WITHDRAWN
- Phase
- PHASE2
Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function
- Status
- UNKNOWN
- Phase
- PHASE4
Non-interventional Study of Moderate to Severe Inflammatory Bowel Disease in Brazil
- Status
- COMPLETED
- Phase
- N/A
A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of TAK-828 Escalating Multiple-Doses in Healthy Participants
- Status
- TERMINATED
- Phase
- PHASE1
Cyclobenzaprine HCl Extended Release 15 mg Versus Placebo in Treatment of Cervical and/or Lower Back Pain Due to Muscle Spasms of Local Origin
- Status
- COMPLETED
- Phase
- PHASE3
A Food Effect Study of TAK-385 Final Formulation
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
- Status
- COMPLETED
- Phase
- PHASE4
A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas
- Status
- COMPLETED
- Phase
- N/A
TAK-438_110 Drug Interaction With Cytochrome P450 3A4 (CYP3A4) Inhibitor Clarithromycin
- Status
- COMPLETED
- Phase
- PHASE1
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE4
Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants
- Status
- TERMINATED
- Phase
- PHASE1
Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE4
Triple Combination Therapy in High Risk Crohn's Disease (CD)
- Status
- COMPLETED
- Phase
- PHASE4
Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation
- Status
- UNKNOWN
- Phase
- PHASE3
An Extension Study of PEAK Trial
- Status
- TERMINATED
- Phase
- PHASE4
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
- Status
- TERMINATED
- Phase
- N/A
Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study
- Status
- WITHDRAWN
- Phase
- PHASE4